查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1333414

細胞裂解/細胞分級的全球市場

Cell Lysis / Cell Fractionation
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

到 2030 年，全球細胞裂解/分離市場將達到 44 億美元

在 COVID-19 後不斷變化的商業環境中，細胞裂解/細胞分離的全球市場規模預計 2022 年為 28 億美元，預計到 2030 年將達到 44 億美元。預計年複合成長率為到2030 年將成長5.9%。消耗品是本報告分析的細分市場之一，預計複合年成長率為 6.9%，到分析期結束時將達到 28 億美元。鑑於疫情后的持續復甦，未來八年設備領域的複合年複合成長率修正為4.3%。

美國市場預計將成長8.23億美元，中國年複合成長率為5.4%

到 2022 年，美國細胞裂解/分級分離市場預計將達到 8.23 億美元。中國作為世界第二大經濟體，預計到2030年市場規模將達到7.748億美元，2022年至2030年的分析期間年複合成長率為5.4%。其他值得注意的地域市場包括日本和加拿大，預計 2022 年至 2030 年將分別成長 5.3% 和 4.8%。在歐洲，德國的年複合成長率預計約為 4.4%。

受訪企業示例

  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Cell Signaling Technology, Inc.
  • Merck KgaA
  • Miltenyi Biotec GmbH
  • Qiagen NV
  • Qsonica LLC
  • Roche Diagnostics
  • Thermo Fisher Scientific, Inc.

目錄

第1章 調查方法

第2章 執行摘要

  • 市場概況
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場預測

第3章 市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 其他歐洲國家
  • 亞太地區
  • 世界其他地區

第4章 競爭

簡介目錄
Product Code: MCP10947

What`s New for 2023?

»Special coverage on Russia-Ukraine war; global inflation; easing of "zero-Covid" policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.

»Global competitiveness and key competitor percentage market shares

» Market presence across multiple geographies - Strong/Active/Niche/Trivial

»Online interactive peer-to-peer collaborative bespoke updates

»Access to our digital archives and MarketGlass Research Platform

»Complimentary updates for one year

Looking Ahead to 2023

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Cell Lysis / Cell Fractionation Market to Reach $4.4 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Cell Lysis / Cell Fractionation estimated at US$2.8 Billion in the year 2022, is projected to reach a revised size of US$4.4 Billion by 2030, growing at aCAGR of 5.9% over the period 2022-2030. Consumables, one of the segments analyzed in the report, is projected to record 6.9% CAGR and reach US$2.8 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Instruments segment is readjusted to a revised 4.3% CAGR for the next 8-year period.

The U.S. Market is Estimated at $823 Million, While China is Forecast to Grow at 5.4% CAGR

The Cell Lysis / Cell Fractionation market in the U.S. is estimated at US$823 Million in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$774.8 Million by the year 2030 trailing a CAGR of 5.4% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.3% and 4.8% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 4.4% CAGR.

Select Competitors (Total 44 Featured) -

  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Cell Signaling Technology, Inc.
  • Merck KgaA
  • Miltenyi Biotec GmbH
  • Qiagen NV
  • Qsonica L.L.C.
  • Roche Diagnostics
  • Thermo Fisher Scientific, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Cell Lysis/Cell Fractionation - Global Key Competitors Percentage Market Share in 2022 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Cell Lysis / Cell Fractionation Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 3: World 8-Year Perspective for Cell Lysis / Cell Fractionation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2023 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 5: World 8-Year Perspective for Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 7: World 8-Year Perspective for Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Mammalian Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 9: World 8-Year Perspective for Mammalian Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Microbial Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 11: World 8-Year Perspective for Microbial Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 13: World 8-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Research Laboratories & Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 15: World 8-Year Perspective for Research Laboratories & Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 17: World 8-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 19: World 8-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Cell Lysis / Cell Fractionation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Component - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 21: USA 8-Year Perspective for Cell Lysis / Cell Fractionation by Component - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2023 & 2030
    • TABLE 22: USA Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Type - Mammalian Cells, Microbial Cells and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 23: USA 8-Year Perspective for Cell Lysis / Cell Fractionation by Type - Percentage Breakdown of Value Sales for Mammalian Cells, Microbial Cells and Other Types for the Years 2023 & 2030
    • TABLE 24: USA Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by End-Use - Research Laboratories & Institutes, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 25: USA 8-Year Perspective for Cell Lysis / Cell Fractionation by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Institutes, Pharma & Biotech Companies and Other End-Uses for the Years 2023 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Component - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 27: Canada 8-Year Perspective for Cell Lysis / Cell Fractionation by Component - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2023 & 2030
    • TABLE 28: Canada Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Type - Mammalian Cells, Microbial Cells and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 29: Canada 8-Year Perspective for Cell Lysis / Cell Fractionation by Type - Percentage Breakdown of Value Sales for Mammalian Cells, Microbial Cells and Other Types for the Years 2023 & 2030
    • TABLE 30: Canada Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by End-Use - Research Laboratories & Institutes, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 31: Canada 8-Year Perspective for Cell Lysis / Cell Fractionation by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Institutes, Pharma & Biotech Companies and Other End-Uses for the Years 2023 & 2030
  • JAPAN
    • Cell Lysis / Cell Fractionation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Component - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 33: Japan 8-Year Perspective for Cell Lysis / Cell Fractionation by Component - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2023 & 2030
    • TABLE 34: Japan Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Type - Mammalian Cells, Microbial Cells and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 35: Japan 8-Year Perspective for Cell Lysis / Cell Fractionation by Type - Percentage Breakdown of Value Sales for Mammalian Cells, Microbial Cells and Other Types for the Years 2023 & 2030
    • TABLE 36: Japan Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by End-Use - Research Laboratories & Institutes, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 37: Japan 8-Year Perspective for Cell Lysis / Cell Fractionation by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Institutes, Pharma & Biotech Companies and Other End-Uses for the Years 2023 & 2030
  • CHINA
    • Cell Lysis / Cell Fractionation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Component - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 39: China 8-Year Perspective for Cell Lysis / Cell Fractionation by Component - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2023 & 2030
    • TABLE 40: China Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Type - Mammalian Cells, Microbial Cells and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 41: China 8-Year Perspective for Cell Lysis / Cell Fractionation by Type - Percentage Breakdown of Value Sales for Mammalian Cells, Microbial Cells and Other Types for the Years 2023 & 2030
    • TABLE 42: China Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by End-Use - Research Laboratories & Institutes, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 43: China 8-Year Perspective for Cell Lysis / Cell Fractionation by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Institutes, Pharma & Biotech Companies and Other End-Uses for the Years 2023 & 2030
  • EUROPE
    • Cell Lysis / Cell Fractionation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
    • TABLE 45: Europe 8-Year Perspective for Cell Lysis / Cell Fractionation by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2023 & 2030
    • TABLE 46: Europe Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Component - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 47: Europe 8-Year Perspective for Cell Lysis / Cell Fractionation by Component - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2023 & 2030
    • TABLE 48: Europe Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Type - Mammalian Cells, Microbial Cells and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 49: Europe 8-Year Perspective for Cell Lysis / Cell Fractionation by Type - Percentage Breakdown of Value Sales for Mammalian Cells, Microbial Cells and Other Types for the Years 2023 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by End-Use - Research Laboratories & Institutes, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 51: Europe 8-Year Perspective for Cell Lysis / Cell Fractionation by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Institutes, Pharma & Biotech Companies and Other End-Uses for the Years 2023 & 2030
  • FRANCE
    • Cell Lysis / Cell Fractionation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
    • TABLE 52: France Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Component - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 53: France 8-Year Perspective for Cell Lysis / Cell Fractionation by Component - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2023 & 2030
    • TABLE 54: France Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Type - Mammalian Cells, Microbial Cells and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 55: France 8-Year Perspective for Cell Lysis / Cell Fractionation by Type - Percentage Breakdown of Value Sales for Mammalian Cells, Microbial Cells and Other Types for the Years 2023 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by End-Use - Research Laboratories & Institutes, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 57: France 8-Year Perspective for Cell Lysis / Cell Fractionation by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Institutes, Pharma & Biotech Companies and Other End-Uses for the Years 2023 & 2030
  • GERMANY
    • Cell Lysis / Cell Fractionation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
    • TABLE 58: Germany Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Component - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 59: Germany 8-Year Perspective for Cell Lysis / Cell Fractionation by Component - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2023 & 2030
    • TABLE 60: Germany Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Type - Mammalian Cells, Microbial Cells and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 61: Germany 8-Year Perspective for Cell Lysis / Cell Fractionation by Type - Percentage Breakdown of Value Sales for Mammalian Cells, Microbial Cells and Other Types for the Years 2023 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by End-Use - Research Laboratories & Institutes, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 63: Germany 8-Year Perspective for Cell Lysis / Cell Fractionation by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Institutes, Pharma & Biotech Companies and Other End-Uses for the Years 2023 & 2030
  • ITALY
    • TABLE 64: Italy Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Component - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 65: Italy 8-Year Perspective for Cell Lysis / Cell Fractionation by Component - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2023 & 2030
    • TABLE 66: Italy Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Type - Mammalian Cells, Microbial Cells and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 67: Italy 8-Year Perspective for Cell Lysis / Cell Fractionation by Type - Percentage Breakdown of Value Sales for Mammalian Cells, Microbial Cells and Other Types for the Years 2023 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by End-Use - Research Laboratories & Institutes, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 69: Italy 8-Year Perspective for Cell Lysis / Cell Fractionation by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Institutes, Pharma & Biotech Companies and Other End-Uses for the Years 2023 & 2030
  • UNITED KINGDOM
    • Cell Lysis / Cell Fractionation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
    • TABLE 70: UK Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Component - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 71: UK 8-Year Perspective for Cell Lysis / Cell Fractionation by Component - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2023 & 2030
    • TABLE 72: UK Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Type - Mammalian Cells, Microbial Cells and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 73: UK 8-Year Perspective for Cell Lysis / Cell Fractionation by Type - Percentage Breakdown of Value Sales for Mammalian Cells, Microbial Cells and Other Types for the Years 2023 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by End-Use - Research Laboratories & Institutes, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 75: UK 8-Year Perspective for Cell Lysis / Cell Fractionation by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Institutes, Pharma & Biotech Companies and Other End-Uses for the Years 2023 & 2030
  • REST OF EUROPE
    • TABLE 76: Rest of Europe Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Component - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 77: Rest of Europe 8-Year Perspective for Cell Lysis / Cell Fractionation by Component - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2023 & 2030
    • TABLE 78: Rest of Europe Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Type - Mammalian Cells, Microbial Cells and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 79: Rest of Europe 8-Year Perspective for Cell Lysis / Cell Fractionation by Type - Percentage Breakdown of Value Sales for Mammalian Cells, Microbial Cells and Other Types for the Years 2023 & 2030
    • TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by End-Use - Research Laboratories & Institutes, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 81: Rest of Europe 8-Year Perspective for Cell Lysis / Cell Fractionation by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Institutes, Pharma & Biotech Companies and Other End-Uses for the Years 2023 & 2030
  • ASIA-PACIFIC
    • Cell Lysis / Cell Fractionation Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
    • TABLE 82: Asia-Pacific Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Component - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 83: Asia-Pacific 8-Year Perspective for Cell Lysis / Cell Fractionation by Component - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2023 & 2030
    • TABLE 84: Asia-Pacific Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Type - Mammalian Cells, Microbial Cells and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 85: Asia-Pacific 8-Year Perspective for Cell Lysis / Cell Fractionation by Type - Percentage Breakdown of Value Sales for Mammalian Cells, Microbial Cells and Other Types for the Years 2023 & 2030
    • TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by End-Use - Research Laboratories & Institutes, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 87: Asia-Pacific 8-Year Perspective for Cell Lysis / Cell Fractionation by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Institutes, Pharma & Biotech Companies and Other End-Uses for the Years 2023 & 2030
  • REST OF WORLD
    • TABLE 88: Rest of World Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Component - Consumables and Instruments - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 89: Rest of World 8-Year Perspective for Cell Lysis / Cell Fractionation by Component - Percentage Breakdown of Value Sales for Consumables and Instruments for the Years 2023 & 2030
    • TABLE 90: Rest of World Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by Type - Mammalian Cells, Microbial Cells and Other Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 91: Rest of World 8-Year Perspective for Cell Lysis / Cell Fractionation by Type - Percentage Breakdown of Value Sales for Mammalian Cells, Microbial Cells and Other Types for the Years 2023 & 2030
    • TABLE 92: Rest of World Recent Past, Current & Future Analysis for Cell Lysis / Cell Fractionation by End-Use - Research Laboratories & Institutes, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
    • TABLE 93: Rest of World 8-Year Perspective for Cell Lysis / Cell Fractionation by End-Use - Percentage Breakdown of Value Sales for Research Laboratories & Institutes, Pharma & Biotech Companies and Other End-Uses for the Years 2023 & 2030

IV. COMPETITION